Literature DB >> 20876515

Emerging risk factors in women.

Kathryn M Rexrode1.   

Abstract

Stroke is a major cause of long-term disability and death for women in the United States, with recent evidence suggesting a higher rate of stroke in midlife women than men, as well as higher lifetime risk of stroke for older women. Several recent studies highlight emerging areas of interest for research on risk factors for stroke in women. This article reviews data published in the last year, focusing on 3 potential risk factors that may partially explain these differences between men and women: central adiposity and related adipocytokines, endogenous sex hormones, and depression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20876515      PMCID: PMC2957189          DOI: 10.1161/STROKEAHA.110.595280

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  25 in total

1.  High-molecular-weight adiponectin and incident ischemic stroke in postmenopausal women: a Women's Health Initiative Study.

Authors:  Alexandra D Ogorodnikova; Sylvia Wassertheil-Smoller; Peter Mancuso; MaryFran R Sowers; Swapnil N Rajpathak; Matthew A Allison; Alison E Baird; Beatriz Rodriguez; Rachel P Wildman
Journal:  Stroke       Date:  2010-05-27       Impact factor: 7.914

2.  A clinical trial of estrogen-replacement therapy after ischemic stroke.

Authors:  C M Viscoli; L M Brass; W N Kernan; P M Sarrel; S Suissa; R I Horwitz
Journal:  N Engl J Med       Date:  2001-10-25       Impact factor: 91.245

3.  Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.

Authors:  F Grodstein; M J Stampfer; J E Manson; G A Colditz; W C Willett; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

4.  Sex hormone levels and risk of cardiovascular events in postmenopausal women.

Authors:  Kathryn M Rexrode; JoAnn E Manson; I-Min Lee; Paul M Ridker; Patrick M Sluss; Nancy R Cook; Julie E Buring
Journal:  Circulation       Date:  2003-09-15       Impact factor: 29.690

5.  Endogenous estradiol and risk of dementia in women and men: the Rotterdam Study.

Authors:  Mirjam I Geerlings; Lenore J Launer; Frank H de Jong; Annemieke Ruitenberg; Theo Stijnen; John C van Swieten; Albert Hofman; Jacqueline C M Witteman; Huibert A P Pols; Monique M B Breteler
Journal:  Ann Neurol       Date:  2003-05       Impact factor: 10.422

Review 6.  Hepatocyte growth factor as cardiovascular hormone: role of HGF in the pathogenesis of cardiovascular disease.

Authors:  Ryuichi Morishita; Motokuni Aoki; Yoshikage Yo; Toshio Ogihara
Journal:  Endocr J       Date:  2002-06       Impact factor: 2.349

7.  Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.

Authors:  Sylvia Wassertheil-Smoller; Susan L Hendrix; Marian Limacher; Gerardo Heiss; Charles Kooperberg; Alison Baird; Theodore Kotchen; J David Curb; Henry Black; Jacques E Rossouw; Aaron Aragaki; Monika Safford; Evan Stein; Somchai Laowattana; W Jerry Mysiw
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

8.  Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI).

Authors:  Sylvia Wassertheil-Smoller; Sally Shumaker; Judith Ockene; Greg A Talavera; Philip Greenland; Barbara Cochrane; John Robbins; Aaron Aragaki; Jacqueline Dunbar-Jacob
Journal:  Arch Intern Med       Date:  2004-02-09

9.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

10.  Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women.

Authors:  E Barrett-Connor; D Goodman-Gruen
Journal:  BMJ       Date:  1995-11-04
View more
  5 in total

Review 1.  Sexual dimorphism in ischemic stroke: lessons from the laboratory.

Authors:  Bharti Manwani; Louise D McCullough
Journal:  Womens Health (Lond)       Date:  2011-05

2.  Gut microbiota accelerates obesity in peri-/post-menopausal women via Bacteroides fragilis and acetic acid.

Authors:  Wen-Di Shen; Xu Lin; Hui-Min Liu; Bo-Yang Li; Xiang Qiu; Wan-Qiang Lv; Xue-Zhen Zhu; Jonathan Greenbaum; Rui-Ke Liu; Jie Shen; Hong-Mei Xiao; Hong-Wen Deng
Journal:  Int J Obes (Lond)       Date:  2022-08-17       Impact factor: 5.551

3.  Anti-osteoporosis effect of 5-bromo-2-(4-chlorobenzoyl)-(Z)-3-(2-cyano-3-hydroxybut-2-enonyl)aminobenzo[b]furan: a novel selective estrogen receptor modulator.

Authors:  Ryo Fukuyama; Akio Shimokawa; Yasushi Kodama; Mitsugu Fujita; Yoshitaka Ohishi; Yuko Ando; Masao Koida; Hiromichi Nakamuta
Journal:  J Pharmacol Sci       Date:  2011-05-21       Impact factor: 3.337

Review 4.  Women Health in Saudi Arabia: A review of non-communicable diseases and their risk factors.

Authors:  Aljoharah M Alquaiz; Amna R Siddiqui; Riaz H Qureshi; Mona A Fouda; Maha A Almuneef; Fawzia A Habib; Iqbal M Turkistani
Journal:  Pak J Med Sci       Date:  2014-03       Impact factor: 1.088

5.  Age- and sex-specific rates of leukoaraiosis in TIA and stroke patients: population-based study.

Authors:  Michela Simoni; Linxin Li; Nicola L M Paul; Basil E Gruter; Ursula G Schulz; Wilhelm Küker; Peter M Rothwell
Journal:  Neurology       Date:  2012-09-05       Impact factor: 9.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.